NASDAQ:SAVA Archives - BioPharmaJournal

Home Tags NASDAQ:SAVA

Cassava Sciences Inc. (NASDAQ: SAVA) Launches New Clinical Website Offering Information...

Gavins Felicity - January 3, 2022 0

Journal of Neuroscience Didn’t Find Data Manipulation Evidence in Research Article...

Matt Wade - November 17, 2021 0

Annovis Bio Inc (NYSEAMERICAN: ANVS), Cassava Sciences Inc (NASDAQ: SAVA), Honest...

Kate Hudson - October 11, 2021 0

Cassava Sciences Inc. (NASDAQ: SAVA) Releases Clinical Data On Simufilam In...

Matt Wade - September 28, 2021 0

Cassava Sciences Inc. (NASDAQ:SAVA) Released Addition Phase 2b Clinical Study Results...

Ward Sport - November 10, 2020 0

CTAD 2020 Picks Cassava Sciences Inc.’s (NASDAQ:SAVA) Phase 2b Sumifilam Study...

Matt Wade - October 14, 2020 0

Cassava Sciences Inc. (NASDAQ:SAVA) Demonstrates Directional Improvement In Alzheimer’s Patients Treated...

Matt Wade - September 17, 2020 0

The USAN Announces a Commercial Brand Name for PTI-125; Lead Drug...

Kate Hudson - September 1, 2020 0

Cassava Sciences Inc (NASDAQ:SAVA) Expects To Release Clinical Results Of Phase...

Kate Hudson - August 26, 2020 0

Recent Post

Lucid Motors (LCID) could be a falling knife for retail traders

Kate Hudson - January 27, 2023 0

The stock of Lucid (NASDAQ:LCID) saw a significant increase on Friday, with the price nearly doubling before trading was halted. The stock...

BuzzFeed Inc (NASDAQ:BZFD) surge could be just getting started

January 26, 2023

Invesco QQQ Trust Series 1 (NASDAQ:QQQ) looks to bounce back as...

January 25, 2023

Esports Entertainment Group Inc (GMBL) could keep surging as online iGaming...

January 24, 2023

Microsoft (MSFT) post disappointing revenue forecast for current quarter

January 24, 2023